$REPL

Replimune Group, Inc.

CIK:0001737953|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating expenses:
Research and development	$ 49,277	$ 57,843
Selling, general and administrative	18,970	32,579
Total operating expenses	68,247	90,422
Loss from operations	(68,247)	(90,422)
Other income (expense):
Research and development incentives	296	420
Investment income	1,960	4,714
Interest expense on finance lease liability	(506)	(521)
Interest expense on debt obligations	(2,581)	(1,475)
Other (expense) income, net	(688)	591
Total other (expense) income, net	(1,519)	3,729
Net loss	$ (69,766)	$ (86,693)
Net loss per common share, basic (in dollars per share)	$ (0.72)	$ (0.95)
Net loss per common share, diluted (in dollars per share)	$ (0.72)	$ (0.95)
Weighted average common shares outstanding, basic (in shares)	96,864,452	91,516,199
Weighted average common shares outstanding, diluted (in shares)	96,864,452	91,516,199

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net loss	$ (69,766)	$ (86,693)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	7,674	8,762
Depreciation and amortization	937	873
Operating lease, right-of-use-asset amortization	206	185
Finance lease, right-of-use-asset amortization	607	607
Net amortization of premiums and discounts on short-term investments	(112)	(1,339)
Impairment on property, plant and equipment	108	0
Noncash interest expense	806	415
Unrealized foreign currency transaction (gains) losses	(688)	591
Changes in operating assets and liabilities:
Research and development incentives receivable	1,347	1,631
Prepaid expenses and other current assets	3,129	234
Accounts payable	(2,334)	3,765
Accrued expenses and other current liabilities	(17,424)	(5,536)
Operating lease liabilities	(218)	(195)
Other non-current liabilities	0	(316)
Net cash used in operating activities	(75,728)	(77,016)
Cash flows from investing activities:
Purchases of property, plant and equipment and software capitalization	(6)	(2,740)
Purchase of short-term investments	(9,884)	(37,581)
Proceeds from sales and maturities of short-term investments	59,883	105,369
Net cash provided by investing activities	49,993	65,048
Cash flows from financing activities:
Principal payment of finance lease obligation	(203)	(166)
Proceeds from exercise of stock options	1,003	8
Net cash provided by (used in) financing activities	800	(158)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	1,270	(1,616)
Net decrease in cash, cash equivalents and restricted cash	(23,665)	(13,742)
Cash, cash equivalents and restricted cash at beginning of period	210,727	112,822
Cash, cash equivalents and restricted cash at end of period	187,062	99,080
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	1,775	1,059
Cash paid for income taxes, net	33	0
Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment included in accounts payable and accrued expenses	$ 3	$ 645

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2026	Mar. 31, 2026
Current assets:
Cash and cash equivalents	$ 185,359	$ 209,024
Short-term investments	9,969	59,865
Research and development incentives receivable	0	1,619
Prepaid expenses and other current assets	5,479	8,611
Total current assets	200,807	279,119
Property, plant and equipment, net	11,858	12,974
Restricted cash	1,703	1,703
Other non-current assets	3,238	2,942
Right-of-use asset - operating leases	3,068	3,270
Right-of-use asset - finance leases	31,773	32,380
Total assets	252,447	332,388
Current liabilities:
Accounts payable	4,261	6,671
Accrued expenses and other current liabilities	30,111	47,516
Operating lease liabilities, current	1,136	1,158
Finance lease liabilities, current	2,904	2,883
Total current liabilities	38,412	58,228
Operating lease liabilities, non-current	2,136	2,328
Finance lease liabilities, non-current	21,685	21,909
Long term debt, net of discount	84,114	83,308
Other liabilities, non-current	455	455
Total liabilities	146,802	166,228
Commitments and contingencies (Note 14)
Stockholders' equity
Common stock, $0.001 par value; 150,000,000 shares authorized as of June 30, 2026 and March 31, 2026; 83,979,366 and 82,716,923 shares issued and outstanding as of June 30, 2026 and March 31, 2026, respectively	84	82
Additional paid-in capital	1,431,870	1,423,194
Accumulated deficit	(1,332,285)	(1,262,519)
Accumulated other comprehensive income	5,976	5,403
Total stockholders' equity	105,645	166,160
Total liabilities and stockholders' equity	$ 252,447	$ 332,388